Liyan Wan

1.2k total citations
38 papers, 669 citations indexed

About

Liyan Wan is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Liyan Wan has authored 38 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 11 papers in Immunology and 10 papers in Molecular Biology. Recurrent topics in Liyan Wan's work include Autoimmune and Inflammatory Disorders Research (13 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammation biomarkers and pathways (4 papers). Liyan Wan is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (13 papers), Systemic Lupus Erythematosus Research (5 papers) and Inflammation biomarkers and pathways (4 papers). Liyan Wan collaborates with scholars based in China, United States and Croatia. Liyan Wan's co-authors include Xiaoyan Bai, Chengde Yang, Qiongyi Hu, Jian Geng, Tingting Liu, Hui Shi, Junna Ye, Yutong Su, Jialin Teng and Xiaobing Cheng and has published in prestigious journals such as Frontiers in Immunology, Metabolism and Human Pathology.

In The Last Decade

Liyan Wan

37 papers receiving 656 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liyan Wan China 16 256 185 138 135 89 38 669
Debby den Uyl Netherlands 13 219 0.9× 129 0.7× 106 0.8× 330 2.4× 121 1.4× 21 770
Vera Großmann Germany 17 411 1.6× 523 2.8× 76 0.6× 48 0.4× 94 1.1× 43 1.1k
Ying‐Qian Mo China 16 179 0.7× 98 0.5× 115 0.8× 366 2.7× 117 1.3× 63 846
Xiaoxi Zhao China 16 303 1.2× 247 1.3× 90 0.7× 44 0.3× 166 1.9× 79 906
H. Aubert France 13 112 0.4× 218 1.2× 51 0.4× 42 0.3× 80 0.9× 68 714
Krzysztof Chojnowski Poland 15 120 0.5× 356 1.9× 76 0.6× 73 0.5× 52 0.6× 73 704
Laurence Lutteri Belgium 14 211 0.8× 56 0.3× 96 0.7× 160 1.2× 50 0.6× 39 679
Imran Ahmad Canada 15 323 1.3× 245 1.3× 92 0.7× 29 0.2× 225 2.5× 92 1.1k
Silvia Navarro Spain 22 198 0.8× 413 2.2× 106 0.8× 43 0.3× 46 0.5× 47 931
Markus Zeisbrich Germany 12 150 0.6× 131 0.7× 289 2.1× 134 1.0× 77 0.9× 16 663

Countries citing papers authored by Liyan Wan

Since Specialization
Citations

This map shows the geographic impact of Liyan Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liyan Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liyan Wan more than expected).

Fields of papers citing papers by Liyan Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liyan Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liyan Wan. The network helps show where Liyan Wan may publish in the future.

Co-authorship network of co-authors of Liyan Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Liyan Wan. A scholar is included among the top collaborators of Liyan Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liyan Wan. Liyan Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yu, Shuyi, Liyan Wan, Lei Li, et al.. (2025). 68Ga-FAPI-04 PET/CT Imaging for Assessing Renal Tubulointerstitial Fibrosis in Lupus Nephritis. Journal of Nuclear Medicine. 66(3). 418–424. 3 indexed citations
3.
Wan, Liyan, et al.. (2024). Volume-Based Quantitative Measurement of [18F]AlF-NOTA-FAPI-04 PET/CT Uptake Reflects the Disease Activity of IgG4-Related Disease. Molecular Imaging and Biology. 26(5). 753–760. 1 indexed citations
4.
Liang, Junyu, Liyan Wan, Yake Yao, et al.. (2024). An externally validated clinical-laboratory nomogram for myocardial involvement in adult idiopathic-inflammatory-myopathy patients. Clinical Rheumatology. 43(6). 1959–1969. 2 indexed citations
5.
Li, Shuangshuang, Guanhua Xu, Junyu Liang, et al.. (2022). The Role of Advanced Imaging in Gout Management. Frontiers in Immunology. 12. 811323–811323. 14 indexed citations
6.
Wan, Liyan, Yuting Gao, Jieyu Gu, et al.. (2022). Differential diagnostic performance of PET/CT in adult-onset still’s disease and lymphoma: a retrospective pilot study. Quantitative Imaging in Medicine and Surgery. 13(1). 37–48. 4 indexed citations
7.
Hu, Qiongyi, Mengyan Wang, Jinchao Jia, et al.. (2021). Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease. Rheumatology International. 42(1). 149–157. 7 indexed citations
8.
Zhou, Zhuochao, Yijun You, Fan Wang, et al.. (2021). Urine Proteomics Differentiate Primary Thrombotic Antiphospholipid Syndrome From Obstetric Antiphospholipid Syndrome. Frontiers in Immunology. 12. 702425–702425. 4 indexed citations
9.
Wan, Liyan, Yuting Gao, Jieyu Gu, et al.. (2021). Total metabolic lesion volume of lymph nodes measured by 18F-FDG PET/CT: a new predictor of macrophage activation syndrome in adult-onset Still’s disease. Arthritis Research & Therapy. 23(1). 97–97. 12 indexed citations
10.
Jia, Jinchao, Mengyan Wang, Yuning Ma, et al.. (2020). Circulating Neutrophil Extracellular Traps Signature for Identifying Organ Involvement and Response to Glucocorticoid in Adult-Onset Still’s Disease: A Machine Learning Study. Frontiers in Immunology. 11. 563335–563335. 20 indexed citations
11.
Teng, Jialin, Jin Dai, Yutong Su, et al.. (2020). Detection of IgM and IgG antibodies against SARS-CoV-2 in patients with autoimmune diseases. The Lancet Rheumatology. 2(7). e384–e385. 15 indexed citations
12.
Chi, Huihui, Haiyan Jin, Zhihong Wang, et al.. (2020). Anxiety and depression in adult-onset Still’s disease patients and associations with health-related quality of life. Clinical Rheumatology. 39(12). 3723–3732. 6 indexed citations
13.
Hu, Qiongyi, Jieyu Gu, Guannan Geng, et al.. (2019). Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis. Frontiers in Immunology. 9. 3099–3099. 32 indexed citations
14.
Li, Xiao, Liyan Wan, Jian Geng, Chin‐Lee Wu, & Xiaoyan Bai. (2012). Aldehyde Dehydrogenase 1A1 Possesses Stem-Like Properties and Predicts Lung Cancer Patient Outcome. Journal of Thoracic Oncology. 7(8). 1235–1245. 66 indexed citations
15.
Wan, Liyan, Li Xiao, Hong Shen, & Xiaoyan Bai. (2012). Quantitative analysis of EZH2 expression and its correlations with lung cancer patients’ clinical pathological characteristics. Clinical & Translational Oncology. 15(2). 132–138. 25 indexed citations
16.
Chen, Xiaoni, Xiaoping Chen, Si Wang, et al.. (2011). The relationship between visfatin and HOMA-IR in hypertensive patients, and the effect of antihypertensive drugs on visfatin and HOMA-IR in hypertensive patients with insulin resistance. Diabetes Research and Clinical Practice. 94(1). 71–76. 14 indexed citations
17.
Li, Xiao, Liyan Wan, Hong Shen, et al.. (2011). Thyroid Transcription Factor-1 Amplification and Expressions in Lung Adenocarcinoma Tissues and Pleural Effusions Predict Patient Survival and Prognosis. Journal of Thoracic Oncology. 7(1). 76–84. 29 indexed citations
18.
19.
Bai, Xiaoyan, Xiao Li, Liyan Wan, et al.. (2011). Intravascular large B-cell lymphoma of the kidney: A case report. Diagnostic Pathology. 6(1). 86–86. 12 indexed citations
20.
Wan, Liyan, et al.. (2003). Determination of chlorzoxazone and paracetamol in lunan-beite tablet by the new vierordt spectrophotometry. 24(6). 353–355. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026